Similar articles for PMID: 24403466

Year	Number of Results
2003	1
2004	1
2006	3
2007	3
2008	1
2009	4
2010	3
2011	9
2012	4
2013	6
2014	5
2015	6
2016	6
2017	4
2018	3
2020	1
2022	1
2023	1
2024	0

1

Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PET.

Hirakata T, Yanagita Y, Fujisawa T, Fujii T, Kinoshita T, Horikoshi H, Oya N, Akiyoshi T, Iijima M, Miyamoto T, Kuwano H. Hirakata T, et al. Anticancer Res. 2014 Jan;34(1):221-6. Anticancer Res. 2014. PMID: 24403466

2

18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S. Gebhart G, et al. J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092940 Free article. Clinical Trial.

3

Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.

Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV. Kauppi JT, et al. Acta Oncol. 2012 May;51(5):636-44. doi: 10.3109/0284186X.2011.643822. Epub 2012 Jan 2. Acta Oncol. 2012. PMID: 22208782

4

Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.

Uematsu T, Kasami M, Yuen S. Uematsu T, et al. Breast Cancer. 2009;16(2):97-104. doi: 10.1007/s12282-008-0065-9. Epub 2008 Jul 29. Breast Cancer. 2009. PMID: 18663562

5

Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.

Mghanga FP, Lan X, Bakari KH, Li C, Zhang Y. Mghanga FP, et al. Clin Breast Cancer. 2013 Aug;13(4):271-9. doi: 10.1016/j.clbc.2013.02.003. Epub 2013 May 25. Clin Breast Cancer. 2013. PMID: 23714689

6

Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer.

Hyun SH, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY. Hyun SH, et al. Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11. Radiology. 2015. PMID: 25496075

7

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Kauhanen SP, et al. Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa. Ann Surg. 2009. PMID: 19687736

8

Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.

Kim T, Kang DK, An YS, Yim H, Jung YS, Kim KS, Kang SY, Kim TH. Kim T, et al. Acta Radiol. 2014 May;55(4):399-408. doi: 10.1177/0284185113498720. Epub 2013 Aug 20. Acta Radiol. 2014. PMID: 23963151

9

Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).

Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y. Miyata H, et al. Ann Surg Oncol. 2014 Feb;21(2):575-82. doi: 10.1245/s10434-013-3343-5. Epub 2013 Nov 8. Ann Surg Oncol. 2014. PMID: 24201746

10

The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.

Park JS, Moon WK, Lyou CY, Cho N, Kang KW, Chung JK. Park JS, et al. Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142. Acta Radiol. 2011. PMID: 21498321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year